We Think Simulations Plus Solid Earnings Are Understated
SLP Stock | USD 30.82 0.80 2.66% |
Slightly above 55% of Simulations Plus' retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Simulations Plus suggests that some traders are interested. Simulations Plus' investing sentiment overview a quick insight into current market opportunities from investing in Simulations Plus. Many technical investors use Simulations Plus stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Simulations | Build AI portfolio with Simulations Stock |
Despite posting healthy earnings, Simulations Plus, Inc.s stock has been quite weak. Our analysis...
Read at finance.yahoo.com
![]() |
Simulations Plus Fundamental Analysis
We analyze Simulations Plus' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Simulations Plus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Simulations Plus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Simulations Plus is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Simulations Plus Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Simulations Plus stock to make a market-neutral strategy. Peer analysis of Simulations Plus could also be used in its relative valuation, which is a method of valuing Simulations Plus by comparing valuation metrics with similar companies.
Peers
Simulations Plus Related Equities
HCAT | Health Catalyst | 9.44 | ||||
HQY | HealthEquity | 6.92 | ||||
FORA | Forian | 4.19 | ||||
PRVA | Privia Health | 0.16 | ||||
HSTM | HealthStream | 1.40 | ||||
DH | Definitive Healthcare | 2.98 | ||||
NRC | National Research | 3.20 | ||||
EVH | Evolent Health | 16.05 |
Additional Tools for Simulations Stock Analysis
When running Simulations Plus' price analysis, check to measure Simulations Plus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Simulations Plus is operating at the current time. Most of Simulations Plus' value examination focuses on studying past and present price action to predict the probability of Simulations Plus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Simulations Plus' price. Additionally, you may evaluate how the addition of Simulations Plus to your portfolios can decrease your overall portfolio volatility.